임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
36건 표시
- 3상모집 중단 (진행 중)· Immune ThrombocytopeniaRilzabrutinib for the Adult Participants With Chronic ITP Who Have Completed Phase 3 Study in Japan
리드: 사노피
- 3상모집 중단 (진행 중)· Meningococcal InfectionImmunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children and Adolescents in China
리드: 사노피
- 3상모집 중단 (진행 중)· Pneumococcal ImmunizationStudy of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age
리드: 사노피
- 3상모집 중단 (진행 중)· Pneumococcal ImmunizationStudy of the Safety of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age
리드: 사노피
- 3상모집 중단 (진행 중)· Chronic Rhinosinusitis With Nasal PolypsA Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps
리드: 사노피 · 협력: 리제네론
- 3상모집 중단 (진행 중)· Chronic Rhinosinusitis With Nasal PolypsA Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps
리드: 사노피 · 협력: 리제네론
- 3상모집 중단 (진행 중)· Pneumococcal ImmunizationStudy of a 4-Dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age
리드: 사노피
- 3상모집 중단 (진행 중)· Lichen Simplex ChronicusA Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 1)
리드: 사노피 · 협력: 리제네론
- 3상모집 중단 (진행 중)· Lichen Simplex ChronicusA Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 2)
리드: 사노피 · 협력: 리제네론
- 3상모집 중단 (진행 중)· Relapsing Multiple SclerosisA Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
리드: 사노피
- 3상모집 중단 (진행 중)· Chronic Graft Versus Host DiseaseA Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease.
리드: 사노피
- 3상모집 중단 (진행 중)· Chronic Obstructive Pulmonary DiseaseA Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD
리드: 사노피 · 협력: 리제네론
- 3상모집 중단 (진행 중)· Multiple SclerosisEfficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis
리드: 사노피
- 3상모집 중단 (진행 중)· Multiple SclerosisEfficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
리드: 사노피
- 3상모집 중단 (진행 중)· Symptomatic Non-Obstructive Hypertrophic CardiomyopathyPhase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic nHCM
협력: 사노피
- 3상모집 중단 (진행 중)· Plasma Cell Myeloma RecurrentSC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM
리드: 사노피
- 3상모집 중단 (진행 중)· Gaucher's Disease Type IIIStudy to Evaluate the Efficacy and Safety of Venglustat in Adult and Pediatric Patients With Gaucher Disease Type 3
리드: 사노피
- 3상모집 중단 (진행 중)· Glycogen Storage Disease Type IIClinical Study for Treatment-naïve IOPD Babies to Evaluate Efficacy and Safety of ERT With Avalglucosidase Alfa
리드: 사노피
- 3상모집 중단 (진행 중)· Hemophilia ALong-term Safety and Efficacy of Efanesoctocog Alfa (BIVV001) in Previously Treated Patients With Hemophilia A
리드: 사노피
- 3상모집 중단 (진행 중)· Immune ThrombocytopeniaStudy to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)
리드: 사노피
- 3상모집 중단 (진행 중)· Multiple MyelomaIsa-KRd vs KRd in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation (IsKia TRIAL)
협력: 암젠, 사노피
- 3상모집 중단 (진행 중)· Plasma Cell MyelomaIsatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma
리드: 사노피
- 3상모집 중단 (진행 중)· Atopic DermatitisStudy to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD)
리드: 리제네론 · 협력: 사노피
- 3상모집 중단 (진행 중)· Adenocarcinoma of ProstateA Phase III of Cabazitaxel and Pelvic Radiotherapy in Localized Prostate Cancer and High-risk Features of Relapse
협력: 사노피
- 3상모집 중단 (진행 중)· Metastatic Prostate CancerA Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer
협력: 사노피
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.